Article
What is the potential of Lumacaftor as a chemical chaperone in promoting hERG trafficking?
2024-01-30
Abstract excerpt
Lumacaftor (LUM), approved by the FDA for the treatment of cystic fibrosis(CF), has shown great therapeutic potential in protein conformational diseases. As a chemical chaperone, LUM corrects the F508del CFTR mutation and increases the expression of chloride channels on the alveolar cell membrane. After Mehta et al’s research, the selectivity of LUM has been challenged. In human induced pluripotent stem cell-deriv...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4fcd1e54-af81-515a-92b9-85c4488f4308
- DOI
- 10.22541/au.170665535.52632337/v1
